Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: A meta-analysis

International Urogynecology Journal and Pelvic Floor Dysfunction

Volumn 24, Issue 4, 2013, Pages 545-552

  De Vita, Davide ^a   Antell, Henrik ^b,c   Giordano, Salvatore ^d  

^a Obstetrics and Gynecologyc Department S Maria della Speranza   (Italy)

^b BIOMEDICUM HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chondroitin sulfate; Cystitis; Hyaluronic acid; Intravesical instillation; Recurrent urinary tract infections

Indexed keywords

CHONDROITIN SULFATE; CYSTISTAT; HYALURONIC ACID; IALURIL; PLACEBO; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL INFECTION; BLADDER IRRITATION; COMBINATION CHEMOTHERAPY; CYSTITIS; DISEASE DURATION; DRUG EFFICACY; FEMALE; HUMAN; INFECTION RATE; META ANALYSIS; MONOTHERAPY; OUTCOME ASSESSMENT; PELVIC PAIN AND URGENCY FREQUENCY SYMPTOM SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT BACTERIAL CYSTITIS; RECURRENT INFECTION; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; URINARY TRACT INFECTION RATE PER PATIENT YEAR;

ADMINISTRATION, INTRAVESICAL; BACTERIAL INFECTIONS; CHONDROITIN SULFATES; CYSTITIS; FEMALE; HUMANS; HYALURONIC ACID; RECURRENCE; VISCOSUPPLEMENTS;

EID: 84880520939     PISSN: 09373462     EISSN: 14333023     Source Type: Journal    
DOI: 10.1007/s00192-012-1957-y     Document Type: Article

References (39)

1. Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity and economic costs. Am J Med 113:5S-13S (Pubitemid 34756640)
2. Ronald A (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113:14S-9S (Pubitemid 34756641)
3. Chung A, Arianayagam M, Rashid P (2010) Bacterial cystitis in women. Aust Fam Physician 39(5):295-298
4. Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P et al (2000) Risk factors for second urinary tract infection among college women. Am J Epidemiol 151:1194-1205 (Pubitemid 30451952)
5. Avorn J, Monane M, Gurwitz JH et al (1992) Reduction of bacteriuria and pyuria after ingestion of cranberry juice. J Am Med Assoc 271:751-754 (Pubitemid 24074521)
6. Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329:753-756 (Pubitemid 23262529)
7. Reid G (1999) The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 65:3763-3766
8. Schulman CC, Corbusier A, Michiels H et al (1993) Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol 150:917-921 (Pubitemid 23241299)
9. Kruze D, Holzbecher K, Andrial M et al (1989) Urinary antibody response after immunisation with a vaccine against urinary tract infection. Urol Res 17:361-366 (Pubitemid 19278189)
10. Mulvey MA, Lopez-Boado YS, Wilson CL et al (1999) Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494-1497
11. Schilling JD, Mulvey MA, Hultgren SJ (2001) Dynamic interactions between host and pathogen during acute urinary tract infections. Urology 57:56-61 (Pubitemid 33733968)
12. Poggi MM, Johnstone PAS, Conner RJ (2000) Glycosaminoglycan content of human bladders: a method of analysis using coldcup biopsies. Urol Oncol 5:234-237
13. Morales A, Emerson L, Nickel JC (1997) Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology 49:111-113 (Pubitemid 27193962)
14. Parsons CL (1997) Epithelial coating techniques in the treatment of interstitial cystitis. Urology 49:100-104 (Pubitemid 27193959)
15. Daha LK, Riedl CR, Hohlbrugger G et al (2003) Comparative assessment of maximal bladder capacity, 0.9 % NaCl versus 0.2 M KCl, for diagnosis of interstitial cystitis: prospective controlled study. J Urol 170:807-809 (Pubitemid 36999562)
16. Shao Y, Shen ZJ, Rui WB et al (2010) Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. Urology 75(3):547-550
17. Porru D, Leva F, Parmigiani A, et al. (2011) Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. Int Urogynecol J in press (PMID:21904840)
18. Constantinides C, Manousakas T, Nikolopoulos P et al (2004) Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Int 93(9):1262-1266 (Pubitemid 38823949)
19. Lipovac M, Kurz C, Reithmayr F et al (2007) Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. Int J Gynaecol Obstet 96(3):192-195 (Pubitemid 46281918)
20. De Vita D, Giordano S (2012) Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: randomized study. Int Urogynecol J in press (PMID:22614285)
21. Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336-41
22. Haylen BT, de Ridder D, Freeman RM et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5-26
23. Ito T, Tomoe H, Ueda T, Yoshimura N et al (2003) Clinical symptoms scale for interstitial cystitis for diagnosis and for following the course of the disease. Int J Urol 10:S24-26 (Pubitemid 37500724)
24. Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12 (Pubitemid 26120810)
25. Furukawa TA, Barbui C, Cipriani A et al (2006) Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59(1):7-10 (Pubitemid 41797469)
26. Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 20;5:13
27. Stevens JW (2011) A note on dealing with missing standard errors in meta-analyses of continuous outcome measures in WinBUGS. Pharm Stat 10(4):374-8
28. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
29. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-60 (Pubitemid 37088507)
30. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-88 (Pubitemid 17189972)
31. Damiano R, Quarto G, Bava I et al (2011) Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol 59(4):645-651
32. Leppilahti M, Hellström P, Tammela TL (2002) Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 60(1):46-51 (Pubitemid 34722944)
33. Lee DG, Cho JJ, Park HK et al (2010) Preventive effects of hyaluronic acid on Escherichia coli-induced urinary tract infection in rat. Urology 75(4):949-954
34. Tajana G (2009) Fisiopatologia clinica e biologia dell'urotelio. Minerva Uroll Nefrol 61(3):1-31
35. Fraser MO, Lavelle JP, Sacks MS et al (2002) The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy. Rev Urol 4(1):1-11
36. Schulz A, Vestweber AM, Dressler D (2009) Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model. Aktuelle Urol 40(2):109-12
37. Southgate J, Varley CL, Garthwaite MA et al (2007) Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int 99(6):1506-1516 (Pubitemid 47164804)
38. Engelhardt PF, Morakis N, Daha LK et al (2010) Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 22(4):401-405
39. Hooton TM (2001) Recurrent urinary tract infection in women. Int J Antimicrob Agents 17:259-268 (Pubitemid 32288741)